Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Interventions

pembrolizumab 27 Nivolumab 26 cabozantinib 25 Magnetic Resonance Spectroscopy 19 Specimen Handling 16 Ipilimumab 16 lenvatinib 10 belzutifan 7 atezolizumab 7 Biopsy 7 Axitinib 7 Sunitinib 6 Everolimus 6 CTLA-4 Antigen 6 avelumab 5 aldesleukin 5 Radiosurgery 5 Immunoglobulin G 5 Bevacizumab 5 pazopanib 4 fludarabine 4 Disulfides 4 Cyclophosphamide 4 zimberelimab 3 palbociclib 3 cemiplimab 3 Radiotherapy 3 Nephrectomy 3 IFL protocol 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡